Abstract
The retinal toxicity of daunomycin, a drug that effectively suppresses experimental proliferative vitreoretinopathy (PVR), was studied in the rabbit by clinical examination, electroretinography (ERG), light microscopy, and electron microscopy. Although no toxicity was observed at the therapeutically effective dose of 10 nmol per eye, the safety margin is too small to recommend this drug for therapy of proliferative vitreoretinopathy in man.
Similar content being viewed by others
References
Algvere P, Kock E (1976) Experimental fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts. Graefe's Arch Clin Exp Ophthalmol 199:215–222
Blumenkranz MS, Ophir A, Claflin AJ, Hajek A (1982) Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94:458–467
Calabresi P, Parks RE (1980) Antiproliferative agents and drugs used for immunosuppression. In: Gilman AG, Goodman LS, Gilman A (eds) The Pharmacological Basis of Therapeutics, 6th ed. MacMillan, New York, pp 1256–1313
Johnson AT, Kretzer F (1983) Photoreceptor degeneration induced by adriamycin. Invest Ophthalmol Vis Sci 24 (ARVO suppl) p 181
Kirmani M, Santana M, Sorgente N, Wiedemann P, Ryan SJ (1983) Drug treatment of MPP. Invest Ophthalmol Vis Sci 24 (ARVO suppl) p 241
Machemer R (1977) Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 75:556–586
Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77:171–180
Maral RJ, Jouanne M (1981) Toxicology of daunorubicin in animals and man. Cancer Treat Rep [Suppl 65] 4:9–18
Topping TM, Abrams GW, Machemer R (1979) Experimental double-perforating injury of the posterior segment in rabbit eyes. Arch Ophthalmol 97:735–742
Weiss JF, Belkin M (1981) The effect of penicillamine on posttraumatic vitreous proliferation. Am J Ophthalmol 92:625–627
Wiedemann P, Kirmani M, Santana M, Sorgente N, Ryan SJ (1983) Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefe's Arch Clin Exp Ophthalmol 220:233–235
Author information
Authors and Affiliations
Additional information
This work was supported in part by an NIH grant EY03040 and an award from Research to Prevent Blindness, Inc., New York, New York. Presented in part at the ARVO meeting, Sarasota, Florida, USA, 1983
Rights and permissions
About this article
Cite this article
Santana, M., Wiedemann, P., Kirmani, M. et al. Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefe's Arch Clin Exp Ophthalmol 221, 210–213 (1984). https://doi.org/10.1007/BF02134142
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02134142